Date | Time | Source | Headline | Symbol | Company |
06/14/2024 | 6:07AM | iHub Newswire | FeaturedFifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates | | |
05/29/2024 | 8:20AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
05/22/2024 | 9:08AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
05/15/2024 | 9:29AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
05/10/2024 | 5:27PM | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
03/08/2024 | 4:49PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
03/01/2024 | 4:40PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
03/01/2024 | 7:35AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
02/29/2024 | 8:23PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
02/29/2024 | 4:44PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
02/29/2024 | 8:09AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
02/14/2024 | 5:09PM | Edgar (US Regulatory) | Form SC 13D - General statement of acquisition of beneficial ownership | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
02/13/2024 | 3:53PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
02/13/2024 | 8:50AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
02/12/2024 | 1:38PM | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
02/09/2024 | 5:45AM | PR Newswire (US) | Eagle Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 9, 2024 to Discuss Your Rights - EGRX | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
02/07/2024 | 9:15AM | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
02/06/2024 | 5:09PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
02/02/2024 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX) | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
01/26/2024 | 11:49AM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
01/26/2024 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX) | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
01/19/2024 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX) | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
01/18/2024 | 6:56AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
01/18/2024 | 6:50AM | GlobeNewswire Inc. | Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
01/16/2024 | 7:00AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
01/12/2024 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX) | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
01/09/2024 | 5:01PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
01/09/2024 | 5:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
01/05/2024 | 5:45AM | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eagle Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 9, 2024 - (NASDAQ: EGRX) | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |
12/22/2023 | 7:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:EGRX | Eagle Pharmaceuticals Inc |